Cardiff Oncology Inc (CRDF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -21,789 | -10,011 | -41,441 | -32,104 | -22,373 |
| Depreciation Amortization | -76 | -54 | -523 | -421 | -217 |
| Accounts receivable | -163 | -105 | 483 | 573 | 610 |
| Other Working Capital | 2,592 | 1,201 | 6,568 | 5,177 | 4,154 |
| Other Operating Activity | 2,466 | 1,229 | 4,026 | 3,027 | 2,035 |
| Operating Cash Flow | $-16,970 | $-7,740 | $-30,887 | $-23,748 | $-15,791 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 18,731 | 4,716 | 36,777 | 23,208 | 19,072 |
| PPE Investments | -80 | -80 | -582 | -574 | -259 |
| Investing Cash Flow | $18,651 | $4,636 | $36,195 | $22,634 | $18,813 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 2,165 | 107 | N/A | N/A | N/A |
| Financing Cash Flow | $2,165 | $107 | $N/A | $N/A | $N/A |
| Beginning Cash Position | 21,655 | 21,655 | 16,347 | 16,347 | 16,347 |
| End Cash Position | 25,501 | 18,658 | 21,655 | 15,233 | 19,369 |
| Net Cash Flow | $3,846 | $-2,997 | $5,308 | $-1,114 | $3,022 |
| Free Cash Flow | |||||
| Operating Cash Flow | -16,970 | -7,740 | -30,887 | -23,748 | -15,791 |
| Capital Expenditure | -80 | -80 | -582 | -574 | -259 |
| Free Cash Flow | -17,050 | -7,820 | -31,469 | -24,322 | -16,050 |